Adenosine
- Product NDC
- 16714-180
- 11-digit product format
- 167140180
- Labeler code
- 16714
- Product ID
- 16714-180_e7361a3c-f159-415e-be44-22663f7540cd
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Adenosine
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Labeler
- Northstar RxLLC
- Application
- ANDA077425
- Marketing category
- ANDA
- Marketing start
- 2021-06-15
- Marketing end
- 2023-04-30
- Substance
- ADENOSINE
- Active strength
- 3 mg/mL
- Pharmacologic classes
- Adenosine Receptor Agonist [EPC], Adenosine Receptor Agonists [MoA]
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 16714-180-01 | 16714018001 | 1 VIAL, SINGLE-DOSE in 1 CARTON (16714-180-01) > 20 mL in 1 VIAL, SINGLE-DOSE | 2021-06-15 | 0000-00-00 | No | No | Current |